Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Haemophilia. 2018 Feb 20;24(3):487–491. doi: 10.1111/hae.13435

Figure 2.

Figure 2

Blocking efficiency of unheated versus heated recombinant (r) factor VIII (FVIII). The percentage of free anti-FVIII IgG4 remaining after incubation of patient plasma with buffer (baseline), rFVIII (black bars) or rFVIII preheated to 56°C for 60 min (grey bars). MFI—median fluorescence intensity